| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 7,5 k € | +32.2% | 5,7 k € | +54.7% | 3,7 k € | -73.0% | 13,6 k € | +289.9% | 3,5 k € | -71.1% | 12,1 k € | -30.0% | 17,2 k € | +15.5% | 14,9 k € | -28.5% | 20,8 k € | +3.6% | 20,1 k € | +59.3% | 12,6 k € | -59.7% | 31,3 k € | +476.5% | -8,3 k € | -152.2% | 15,9 k € | |
| EBITDA | 6,7 k € | +36.7% | 4,9 k € | +67.2% | 2,9 k € | -77.2% | 12,9 k € | +354.7% | 2,8 k € | -75.2% | 11,4 k € | -31.2% | 16,6 k € | +97.7% | 8,4 k € | -58.9% | 20,4 k € | +4.6% | 19,5 k € | +74.2% | 11,2 k € | -61.9% | 29,4 k € | +364.7% | -11,1 k € | -169.7% | 15,9 k € | |
| Operating profit | 6,6 k € | +35.1% | 4,9 k € | +65.3% | 2,9 k € | -77.2% | 12,9 k € | +354.7% | 2,8 k € | -75.2% | 11,4 k € | -31.2% | 16,6 k € | +97.7% | 8,4 k € | -58.9% | 20,4 k € | +4.6% | 19,5 k € | +74.2% | 11,2 k € | -61.9% | 29,4 k € | +364.7% | -11,1 k € | -169.7% | 15,9 k € | |
| Profit/loss | 4,4 k € | +109.1% | 2,1 k € | +514.3% | 342,7 € | -95.7% | 7,9 k € | +943.3% | 755,9 € | -88.9% | 6,8 k € | -34.7% | 10,4 k € | +198.5% | 3,5 k € | -69.6% | 11,5 k € | +4.7% | 11,0 k € | +80.2% | 6,1 k € | -68.2% | 19,1 k € | +262.7% | -11,8 k € | -212.0% | 10,5 k € | |
| Equity | 1,7 k € | -5.3% | 1,8 k € | -68.0% | 5,7 k € | -71.2% | 19,9 k € | -28.7% | 27,9 k € | -24.9% | 37,1 k € | -3.1% | 38,3 k € | -23.2% | 49,9 k € | +7.5% | 46,4 k € | +32.9% | 34,9 k € | +45.8% | 24,0 k € | +34.0% | 17,9 k € | +1521.0% | -1,3 k € | -112.0% | 10,5 k € | |
| Total assets | 9,5 k € | -8.9% | 10,4 k € | -51.4% | 21,4 k € | -44.3% | 38,5 k € | -0.6% | 38,7 k € | -17.5% | 46,9 k € | -23.2% | 61,2 k € | +9.1% | 56,1 k € | -2.6% | 57,6 k € | +38.1% | 41,7 k € | +55.8% | 26,7 k € | -4.2% | 27,9 k € | +655.9% | 3,7 k € | -85.2% | 24,9 k € | |
| Cash | 2,8 k € | +388.1% | 566,1 € | -83.0% | 3,3 k € | -81.1% | 17,6 k € | +69.3% | 10,4 k € | -53.3% | 22,2 k € | -3.8% | 23,1 k € | -15.1% | 27,2 k € | -13.2% | 31,4 k € | +32.2% | 23,7 k € | +45.3% | 16,3 k € | -23.4% | 21,3 k € | +3366.7% | 614,8 € | -97.5% | 24,9 k € | |
| Debts | 7,8 k € | -9.6% | 8,6 k € | -45.4% | 15,7 k € | -15.5% | 18,6 k € | +71.8% | 10,8 k € | +10.4% | 9,8 k € | -57.0% | 22,8 k € | +271.6% | 6,1 k € | -44.8% | 11,1 k € | +65.4% | 6,7 k € | +142.8% | 2,8 k € | -72.4% | 10,0 k € | +102.4% | 5,0 k € | -65.7% | 14,4 k € | |
Source: Belgian Official Gazette
Private limited company · Tournai · incorporated on 12/06/2012
Private limited company profitable but thinly capitalised. Cash position rising (+388.1%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure — thin equity (1,7 k €) relative to earnings. The abridged model hides revenue.
NARJISSE is a Private limited company incorporated in 2012. Its main activity is: Specialist medical practice activities. Its registered office is in Tournai.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.